Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
about
Importance and management of micronutrient deficiencies in patients with Alzheimer's diseaseEffects of docosahexaenoic Acid on neurotransmissionSmall molecule analysis and imaging of fatty acids in the zebra finch song system using time-of-flight-secondary ion mass spectrometryCurrent evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice.Neuronal and vascular oxidative stress in Alzheimer's disease.Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cellsDietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injuryModulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline.Lipidomics of Alzheimer's disease.Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology?Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime.Can healthy lifestyle modify risk factors for dementia? Findings from a pilot community-based survey in Chennai (India) and Newcastle (UK).Significance of long chain polyunsaturated fatty acids in human health.Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.Phospholipid and Lipid Derivatives as Potential Neuroprotective CompoundsThe Cognitive Ageing, Nutrition and Neurogenesis (CANN) trial: Design and progress
P2860
Q26852673-A202CFD3-6637-4956-9D9A-A50A2B2CFB1DQ26996552-AEFCCED9-210C-4433-BB89-D1CEB8F866EAQ28742553-00036D08-EABF-4871-8446-06C2693DEA17Q34330929-EA1844D5-7F78-4074-9FD1-80ABDBF00C13Q34629640-64DA3BB0-0106-436A-BD7B-6A3A64B00B07Q35687039-9D75602F-D039-4C8C-95F5-55F32529694FQ35878063-DB392569-045A-4D78-A61E-747557444206Q36862989-5D9BDD03-47AF-4F3A-8D69-64AD94723C0CQ37909028-67B97B5D-31F3-4432-BF71-560EB2CBF9BCQ38150523-3EE6CEDF-79A0-474E-9215-814BD34C5CEAQ38191024-65F6A483-569B-4EB0-9B2D-64B6BCB40B8DQ38413096-A6632B79-F0AB-4FDF-B08A-E8CB68D159E4Q39601921-699B2F51-143F-43B8-8694-42EEA7FC38B6Q40060975-D3DCF7BB-7FBB-4986-8ECF-8CB044A3D73CQ41158349-9658C622-BC05-4668-B1F9-2E46BA896B17Q48748992-33E2EF65-24F9-4515-9462-DCC0E95A1D6FQ52147336-0EBF855C-3A07-4F07-89BA-7257CEB2F19CQ58691421-7F0BEDBD-70F5-4024-82E2-AED003BCAEB7Q58693317-92994E0E-F5F2-49FF-9D15-9A620E740358
P2860
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
@en
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
@nl
type
label
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
@en
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
@nl
prefLabel
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
@en
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
@nl
P1476
Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice.
@en
P2093
Thierry Oster
Thierry Pillot
P304
P356
10.1016/J.BBALIP.2010.02.011
P407
P577
2010-03-06T00:00:00Z